Evolent Health Inc. (EVH)
Evolent Health Statistics
Share Statistics
Evolent Health has 116.59M shares outstanding. The number of shares has increased by 0.33% in one year.
| Shares Outstanding | 116.59M |
| Shares Change (YoY) | 0.33% |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 113.57M |
| Failed to Deliver (FTD) Shares | 166.27K |
| FTD / Avg. Volume | 6.63% |
Short Selling Information
The latest short interest is 11.29M, so 9.69% of the outstanding shares have been sold short.
| Short Interest | 11.29M |
| Short % of Shares Out | 9.69% |
| Short % of Float | 10.01% |
| Short Ratio (days to cover) | 5.2 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is 14.2. Evolent Health's PEG ratio is undefined.
| PE Ratio | undefined |
| Forward PE | 14.2 |
| PS Ratio | 0.51 |
| Forward PS | 0.3 |
| PB Ratio | 1.29 |
| P/FCF Ratio | undefined |
| PEG Ratio | undefined |
Enterprise Valuation
Evolent Health Inc. has an Enterprise Value (EV) of 4.13B.
| EV / Earnings | -66.97 |
| EV / Sales | 1.62 |
| EV / EBITDA | 51.55 |
| EV / EBIT | -101.93 |
| EV / FCF | -673.4 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of undefined.
| Current Ratio | 0.85 |
| Quick Ratio | 0.85 |
| Debt / Equity | undefined |
| Total Debt / Capitalization | 18.23 |
| Cash Flow / Debt | 0.08 |
| Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is -0.06% and return on capital (ROIC) is -3.23%.
| Return on Equity (ROE) | -0.06% |
| Return on Assets (ROA) | -0.02% |
| Return on Capital (ROIC) | -3.23% |
| Revenue Per Employee | $567,720.22 |
| Profits Per Employee | $-13,694 |
| Employee Count | 4,500 |
| Asset Turnover | 1 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.41M |
| Effective Tax Rate | 0.02 |
Stock Price Statistics
The stock price has increased by -70.31% in the last 52 weeks. The beta is 1.49, so Evolent Health's price volatility has been higher than the market average.
| Beta | 1.49 |
| 52-Week Price Change | -70.31% |
| 50-Day Moving Average | 9.8 |
| 200-Day Moving Average | 18.19 |
| Relative Strength Index (RSI) | 46.58 |
| Average Volume (20 Days) | 2.51M |
Income Statement
In the last 12 months, Evolent Health had revenue of 2.55B and earned -61.62M in profits. Earnings per share was -0.81.
| Revenue | 2.55B |
| Gross Profit | 367.35M |
| Operating Income | -40.48M |
| Net Income | -61.62M |
| EBITDA | 80.06M |
| EBIT | -40.48M |
| Earnings Per Share (EPS) | -0.81 |
Balance Sheet
The company has 104.2M in cash and 223.15M in debt, giving a net cash position of -118.95M.
| Cash & Cash Equivalents | 104.2M |
| Total Debt | 223.15M |
| Net Cash | -118.95M |
| Retained Earnings | -780.82M |
| Total Assets | 2.54B |
| Working Capital | -108.38M |
Cash Flow
In the last 12 months, operating cash flow was 18.77M and capital expenditures -24.89M, giving a free cash flow of -6.13M.
| Operating Cash Flow | 18.77M |
| Capital Expenditures | -24.89M |
| Free Cash Flow | -6.13M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 14.38%, with operating and profit margins of -1.58% and -2.41%.
| Gross Margin | 14.38% |
| Operating Margin | -1.58% |
| Pretax Margin | -2.47% |
| Profit Margin | -2.41% |
| EBITDA Margin | 3.13% |
| EBIT Margin | -1.58% |
| FCF Margin | -0.24% |
Dividends & Yields
EVH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -8.54% |
| FCF Yield | -0.55% |
Analyst Forecast
The average price target for EVH is $15, which is 58.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $15 |
| Price Target Difference | 58.2% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
Scores
| Altman Z-Score | 0.91 |
| Piotroski F-Score | 4 |